ARCHIVES

Imbruvica Improves PFS, OS In Phase III CLL Study

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI’s Kramer Named Director, NIH Medical Applications Office.

June 16, 2000

Obituary: Michael Potter, 89, NIH Researcher

June 26, 2013

Heart Failure Rare Among Leukemia Patients On Imatinib

September 28, 2007

Also in this 8-page issue: American Legacy Foundation calls Time Inc. a “hero” of tobacco control, but antismoking activists see villain. Time Inc. and parent Time Warner hasn’t made progress in reducing tobacco advertising in magazines, movies, researchers say.

March 4, 2005

Martha Fewell, Assistant To NCI Directors, To Retire

May 3, 2002

Bush Signs HHS Appropriations; NCI Budget $4.188B After Administrative Rescission.

January 11, 2002